Macquarie bullish on Suven Pharma, Divi’s Labs, Bluejet and Syngene

February 20, 2025

Macquarie said that the sector is currently at a turning point, driven by increased pharmaceutical outsourcing due to drug pricing pressures and geopolitical factors, prompting a global restructuring of the pharmaceutical supply chain.

More To Explore

Warren Buffett celebrates Berkshire Hathaway’s success over 60 years as CEO while admitting mistakes

Warren Buffett highlighted Berkshire Hathaway’s achievements over the past year and six decades, praising successor Greg Abel’s readiness to seize investment opportunities. With $334.201 billion

February 22, 2025

Tariff woes extend smallcap selloff as over 400 stocks fall up to 53% this week

Over 400 smallcap stocks saw negative returns during the week, with 23 experiencing double-digit losses. Suratwala Business Group was the biggest loser at -53%, followed

February 22, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003